CGM Reimbursement

tim2000s

Expert
Retired Moderator
Messages
8,934
Type of diabetes
Type 1
Treatment type
Other
Do you know how much the trust pays for the sensors? Also were they ever covered before? My research suggests that it was recently decided they would not cover them unless hyper unaware. I could be off though for sure
They weren't ever covered by CCGs. The most recent NICE guidelines actually encourage them for Hypo unawaremess, making it easier to fight for them if this is going on. This is what the 2015 guidelines say:

Continuous glucose monitoring
1.6.21Do not offer real‑time continuous glucose monitoring routinely to adults with type 1 diabetes. [new 2015]

1.6.22Consider real‑time continuous glucose monitoring for adults with type 1 diabetes who are willing to commit to using it at least 70% of the time and to calibrate it as needed, and who have any of the following despite optimised use of insulin therapy and conventional blood glucose monitoring:

  • More than 1 episode a year of severe hypoglycaemia with no obviously preventable precipitating cause.

  • Complete loss of awareness of hypoglycaemia.

  • Frequent (more than 2 episodes a week) asymptomatic hypoglycaemia that is causing problems with daily activities.

  • Extreme fear of hypoglycaemia.

  • Hyperglycaemia (HbA1c level of 75 mmol/mol [9%] or higher) that persists despite testing at least 10 times a day (see recommendations 1.6.11 and 1.6.12). Continue real‑time continuous glucose monitoring only if HbA1c can be sustained at or below 53 mmol/mol (7%) and/or there has been a fall in HbA1c of 27 mmol/mol (2.5%) or more. [new 2015]
1.6.23For adults with type 1 diabetes who are having real‑time continuous glucose monitoring, use the principles of flexible insulin therapy with either a multiple daily injection insulin regimen or continuous subcutaneous insulin infusion (CSII or insulin pump) therapy. [new 2015]

1.6.24Real-time continuous glucose monitoring should be provided by a centre with expertise in its use, as part of strategies to optimise a person's HbA1c levels and reduce the frequency of hypoglycaemic episodes. [new 2015]

The 2005 Guidelines stated:
 
  • Like
Reactions: 2 people